BioSpace News Archive

The growth of the global medical thawing system market is driven by the demand for this system in laboratories and blood banks.

Transparency Market Research has published a new report titled, “Gene Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.

Transparency Market Research delivers key insights on the global digital dose inhalers market.

The global diagnostic imaging market is expected to grow at a robust 6.0% CAGR during 2018-2026.

Valneva SE, a specialty vaccine company, announced the successful completion of the Phase 3 pivotal trial of its single-shot chikungunya vaccine candidate, VLA1553.

Basilea Pharmaceutica Ltd. reported that preclinical data on the single agent anti-cancer activity of the drug candidate BAL0891 have been presented at the Targeted Anticancer Therapies congress 2022 of the European Society of Medical Oncology, which is taking place online March 7-8, 2022.

NEC OncoImmunity announced that the companies have signed an agreement under which NOI will acquire all of VAXIMM’s neoantigen program assets.

Inventiva announced that the U.S. Food and Drug Administration has completed its safety review of the IND application and has concluded that the proof-of-concept Phase II combination trial with its lead drug candidate lanifibranor and the SGLT2 inhibitor empagliflozin1 in patients with Type 2 Diabetes and non-cirrhotic NASH may proceed.

Prestige BioPharma Limited announced that the preclinical data of their First-in-Class pancreatic cancer treatment, PBP1510, has been shared in a poster presentation at the European Society for Medical Oncology Targeted Anticancer Therapies Congress 2022 held virtually on March 7-8, 2022.

A new DNA sequencing based test method developed by a team led by Ira Deveson, Head of Genomics Technologies at the Garvan Institute of Medical Research and collaborators, has been shown to screen for more than 50 genetic neurological and neuromuscular diseases.